In vitro demonstration of chromosome abnormalities in murine mammary tumor cells. Influence of the technic
Chabanas, A.; Mouriquand, C.
Pathologie-Biologie 21(7): 793-796
1973
ISSN/ISBN: 0369-8114 PMID: 4584852 Document Number: 69545
Document emailed within 1 workday
Related Documents
Dei, T.; Masuko, K.; Ishii, H.; Makita, T.; Tachibana, T. 1986: Novel antigen expression on syngeneic somatic cell hybrids of murine spontaneous mammary tumor cells Journal of the National Cancer Institute 77(2): 511-519Cyong, J.C.; Okada, H.; Ishihara, K.; Hasegawa, F. 1978: Effect of ethanol on cyclic nucleotide levels and the electron microscopic morphology of murine mammary tumor cells Kitasato Archives of Experimental Medicine 51(3-4): 73-80
Li, L.M.; Nicolson, G.L.; Fidler, I.J. 1991: Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells Cancer Research 51(1): 245-254
Ménard, S.; Colnaghi, M.I.; Della Porta, G. 1973: In vitro demonstration of tumor-specific common antigens and embryonal antigens in murine fibrosarcomas induced by 7,12-dimethylbenz(a)anthracene Cancer Research 33(3): 478-481
Spieker, N.; Mareel, M.; Bruyneel, E.A.; Nederbragt, H. 1995: E-cadherin expression and in vitro invasion of canine mammary tumor cells European Journal of Cell Biology 68(4): 427-436
Allison, D.C.; Anderson, S.; Ridolpho, P.F.; Meyne, J.; Robertson, J. 1986: Alterations in the DNA metabolism of MCa-11 mouse mammary tumor cells grown in vivo and in vitro Cancer Research 46(8): 3951-3957
Kramarsky, B.; Lasfargues, E.Y.; Moore, D.H. 1970: Ultrastructural and quantitative studies of mammary tumor virus production in cultured mouse mammary tumor cells Cancer Research 30(4): 1102-1108
Lee, T.L.; Yang, M.L.; Bell, P.B. 1988: Interaction of B16 malignant melanoma tumor cells with the murine mesentery in vitro Cancer Research 48(18): 5296-5301
Soares, F.A.; Shaughnessy, S.G.; MacLarkey, W.R.; Orr, F.W. 1994: Quantification and morphologic demonstration of reactive oxygen species produced by Walker 256 tumor cells in vitro and during metastasis in vivo Laboratory Investigation; A Journal of Technical Methods and Pathology 71(4): 480-489
Hori, T.; Kan, N.; Ohgaki, K.; Yamazaki, N.; Nakayama, N.; Nio, Y.; Inamoto, T. 1984: Tumor-specific cytotoxicity of tumor infiltrating lymphocytes (TIL) induced with TCGF in murine mammary carcinoma Nihon Geka Gakkai Zasshi 85(8): 749-757
Fine, D.L.; Arthur, L.O.; Gardner, M.B. 1978: Prevalence of murine mammary tumor virus antibody and antigens in normal and tumor-bearing feral mice Journal of the National Cancer Institute 61(2): 485-491
Sirotnak, F.M.; Moccio, D.M.; Young, C.W. 1981: Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux Cancer Research 41(3): 966-970
Miner, K.M.; Reading, C.L.; Nicolson, G.L. 1981: In vivo and in vitro production and detection of monoclonal antibodies to surface components on metastatic variants of murine tumor cells Invasion and Metastasis 1(3): 158-174
Chen, M.F.; Suzuki, H.; Yano, S. 1992: Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells Anticancer Research 12(2): 451-456
Phillips, D.H.; Hewer, A.; Grover, P.L. 1985: Aberrant activation of benzo(a)pyrene in cultured rat mammary cells in vitro and following direct application to rat mammary glands in vivo Cancer Research 45(9): 4167-4174
Klein, S. 1996: Immunoregulation of murine mammary tumor growth Medicina 56(Suppl 1): 32-44
Piazzon, I.; Nepomnaschy, I.; Buggiano, V.; Bekinschtein, P.; Goldman, A.; Berguer, P.; Deroche, A.; Lombardi, G. 1997: Superantigens and murine mammary tumor retrovirus Medicina 57(Suppl 2): 21-33
Allione, A.; Consalvo, M.; Nanni, P.; Lollini, P.L.; Cavallo, F.; Giovarelli, M.; Forni, M.; Gulino, A.; Colombo, M.P.; Dellabona, P. 1994: Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants Cancer Research 54(23): 6022-6026
Chattopadhyay, J.; Chatterjee, R.; Chattopadhyay, U.; Chowdhury, J.R. 1984: Purification and partial characterization of a murine mammary tumor-associated antigen Gan 75(4): 334-341
Cividalli, A.; Danesi, D.T.; Altavista, P.; Bonanni, M.; Persiani, D.; Segre, L.; Cruciani, G. 1995: 4'-Epi-doxorubicin and hyperthermia in a murine mammary carcinoma: influence of the dose and fractionation Anticancer Research 15(3): 739-743